Shanghai prioritizes efforts to improve people’s livelihood
BEIJING, Dec. 1, 2023 /PRNewswire/ — A report from People’s Daily: Chinese President Xi Jinping inspected a government-subsidized rental housing community and learned about the city’s efforts in constructing government-subsidized rental housing projects in Shanghai on Nov. 29. It i
FDA Roundup: December 1, 2023
SILVER SPRING, Md., Dec. 1, 2023 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Thursday, the FDA rolled out new tools and FAQs to continue to inform stakeholders about the Food Traceability Rule and help
HLLY Investors Have Opportunity to Lead Holley Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Dec. 1, 2023 /PRNewswire/ — Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Holley Inc. (“Holley” or the “Company”) (NYSE: HLLY). Class Period: Jul
United States Condom Market Analysis Report 2023-2028: Vegan Condoms Gain Traction, Rapid Increase in STIs, and Female Demand Drives Significant Growth
DUBLIN, Dec. 1, 2023 /PRNewswire/ — The “United States Condom Market Competition Forecast & Opportunities, 2028” report has been added to ResearchAndMarkets.com’s offering. United States Condom Market is projected to reach a value of $723 million by 2028 from $412 milli
Yangtze River Delta advances high-quality integrated development
BEIJING, Dec. 1, 2023 /PRNewswire/ — A report from People’s Daily: The Yangtze River Delta is one of the most economically vibrant, open and innovative regions in China. It encompasses four major economic engines – Shanghai, Jiangsu, Zhejiang and Anhui. Shanghai serves as a fronti
Jaypirca® (pirtobrutinib) Now Approved by U.S. FDA for the Treatment of Adult Patients with Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Received at Least Two Lines of Therapy, Including a BTK Inhibitor and a BCL-2 Inhibitor
The first and only non-covalent (reversible) BTK inhibitor, Jaypirca has been shown to extend the benefit of BTK inhibition In the BRUIN Phase 1/2 trial, adult patients with CLL/SLL who have received at least two lines of therapy, including a BTK inhibitor and a BCL-2 inhibitor, achieved an overall
ONE Gas to Participate in BofA, Mizuho, and Wells Fargo Utility Conferences
TULSA, Okla., Dec. 1, 2023 /PRNewswire/ — ONE Gas, Inc. (NYSE: OGS) today announced it will participate in the BofA Securities Gas Utility Conference virtually on Monday, Dec. 4, 2023, followed by the Mizuho Power, Energy, & Infrastructure Conference in the afternoon, in New York City. O
MAA Announces Regular Quarterly Preferred Dividend
GERMANTOWN, Tenn., Dec. 1, 2023 /PRNewswire/ — Mid-America Apartment Communities, Inc., or MAA (NYSE: MAA), today announced a full quarterly dividend of $1.0625 per outstanding share of its 8.50% Series I Cumulative Redeemable Preferred Stock. The dividend is payable on January 2, 2024, to
Morningstar, Inc. Declares Quarterly Dividend of 40.5 Cents Per Share
CHICAGO, Dec. 1, 2023 /PRNewswire/ — The board of directors of Morningstar, Inc. (Nasdaq: MORN), a leading provider of independent investment research, today declared a quarterly dividend of 40.5 cents per share, an increase of 8 percent. The dividend is payable Jan. 31, 2024, to shareholders
STEWART INFORMATION SERVICES CORPORATION ANNOUNCES CASH DIVIDEND
HOUSTON, Dec. 1, 2023 /PRNewswire/ — Stewart Information Services Corporation (NYSE:STC) today announced that its Board of Directors declared a cash dividend of $0.475 per share for the fourth quarter 2023, payable December 29, 2023, to common stockholders of record on December 15, 2023. About
